United States: According to a recent study, common specifics used to treat high blood pressure, cholesterol, and blood sugar may also reduce a person’s threat of stroke.
The threat of brain aneurysms performing in bleeding strokes in individualities was assessed by the experimenters.
In order to conduct the study, the medical records of around 4,900 patients who suffered from bleeding strokes were compared to those of approximately 44,000 individuals who never experienced a brain aneurysm.
Once additional risk variables were taken into consideration, they discovered four particular medications that seemed to reduce the likelihood of a brain aneurysm:
Lisinopril, a medication for high blood pressure, decreased risk by 37%.
Simvastatin, a cholesterol medication, reduced risk by 22%.
Metformin, a medication for diabetes, reduced risk by 42%.
Tamsulosin, a prostate medication, decreased risk by 45%.
According to researcher Jos Peter Kanning of the University Medical Center Utrecht in the Netherlands, “we urgently need new ways to prevent this type of stroke, which occurs at younger ages and with a higher death rate than other types of stroke.”
“Using a noninvasive medication to prevent rupture would be very beneficial, as our current surgical treatments for brain aneurysms often carry a risk of permanent disability and death that exceeds the potential benefits,” Kanning continued in a university news release.
However, four medications elevated the chance of a bleeding stroke: the antipsychotic prochlorperazine, the antidepressant venlafaxine, the blood thinner warfarin, and the analgesic co-codamol.
The researchers pointed out that the results, which were published in the journal Neurology on June 5, merely demonstrate a correlation between these medications and the risk of stroke.
Kanning stated, “Further research is required to examine these correlations and ascertain whether these medications are useful in lowering the risk of hemorrhagic stroke.” “This research may also point to new risk factors for subarachnoid hemorrhage, which could result in aneurysm management treatments.”